EUROBIO-SCIENTIFICEUROBIO-SCIENTIFICEUROBIO-SCIENTIFIC

EUROBIO-SCIENTIFIC

No trades
See on Supercharts
Market capitalization
‪144.68 M‬EUR
‪4.80 M‬EUR
‪130.60 M‬EUR
‪5.27 M‬
Beta (1Y)
−0.02

About EUROBIO-SCIENTIFIC

CEO
Denis Fortier
Headquarters
Les Ulis
Employees (FY)
290
Founded
1997
ISIN
FR0013240934
FIGI
BBG000K48P59
Eurobio-Scientific SA engages in designing, development and commercialization of tests diagnosis in the fields of transplantation, infectious diseases, autoimmunity and oncology, as well as products for research in the field of life sciences. The company was founded on October 15, 1997 and is headquartered in Les Ulis, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALERS is 14.72 EUR — it has decreased by 0.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange EUROBIO-SCIENTIFIC stocks are traded under the ticker ALERS.
ALERS stock is 1.90% volatile and has beta coefficient of −0.02. Check out the list of the most volatile stocks — is EUROBIO-SCIENTIFIC there?
One year price forecast for EUROBIO-SCIENTIFIC has a max estimate of 30.00 EUR and a min estimate of 30.00 EUR.
Yes, you can track EUROBIO-SCIENTIFIC financials in yearly and quarterly reports right on TradingView.
ALERS stock has fallen by 7.07% compared to the previous week, the month change is a 7.77% fall, over the last year EUROBIO-SCIENTIFIC has showed a 9.47% decrease.
ALERS net income for the last quarter is ‪2.61 M‬ EUR, while the quarter before that showed ‪2.19 M‬ EUR of net income which accounts for 19.08% change. Track more EUROBIO-SCIENTIFIC financial stats to get the full picture.
Today EUROBIO-SCIENTIFIC has the market capitalization of ‪135.28 M‬, it has decreased by 0.76% over the last week.
No, ALERS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALERS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EUROBIO-SCIENTIFIC stock right from TradingView charts — choose your broker and connect to your account.
ALERS reached its all-time high on Apr 11, 2007 with the price of 190.26 EUR, and its all-time low was 2.92 EUR and was reached on Dec 24, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 290.00 employees. See our rating of the largest employees — is EUROBIO-SCIENTIFIC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EUROBIO-SCIENTIFIC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EUROBIO-SCIENTIFIC stock shows the sell signal. See more of EUROBIO-SCIENTIFIC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on EUROBIO-SCIENTIFIC future price: according to them, ALERS price has a max estimate of 30.00 EUR and a min estimate of 30.00 EUR. Read a more detailed EUROBIO-SCIENTIFIC forecast: see what analysts think of EUROBIO-SCIENTIFIC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EUROBIO-SCIENTIFIC EBITDA is ‪16.38 M‬ EUR, and current EBITDA margin is 13.78%. See more stats in EUROBIO-SCIENTIFIC financial statements.